PMID,Title,Journal,Year
40897378,"GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study.",The British journal of dermatology,2025
40835981,GLP-1 receptor agonists: emerging therapeutic potential in psoriasis management - current evidence and future outlook.,European journal of clinical pharmacology,2025
39858442,"Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial.",Biomolecules,2025
37918631,[Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases.,Actas dermo-sifiliograficas,2024
37551923,Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes.,"Endocrinology, diabetes & metabolism case reports",2023
34463640,Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient.,"Endocrinology, diabetes & metabolism case reports",2021
33068776,GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art.,Molecular metabolism,2021
